In situ hybridization and immunohistochemistry were used to determine the spectrum of tissues in which interleukin-2 (IL-2) mRNA and protein are found in healthy, normal young mice. In neonatal animals, IL-2 is expressed specifically by distinct, isolated cells at three major sites: the thymus, skin, and gut. Based on morphology and distribution, the IL-2-expressing cells resemble CD3e T cells that are also present in all these locations. Within the thymus of postweanling animals, both TcRafl and TcR),6 lineage cells secrete "haloes" of the cytokine that diffuse over many cell diameters. Within the skin, isolated cells expressing IL-2 are seen at birth in the mesenchyme, and large numbers of IL-2-expressing cells are localized around hair follicles in the epidermis in 3-week-old animals. At this age, a substantial subset of CD3 cells is similarly localized in the skin. Significantly, by 5 weeks of age and later when the CD3e cells are evenly distributed throughout the epidermis, IL-2 RNA and protein expression are no longer detectable. Finally, within the intestine, IL-2 protein is first detected in association with a few discrete, isolated cells at day 16 of gestation and the number of IL-2 reactive cells increases in frequency through El9 and remains abundant in adult life. In postnatal animals, the frequency of IL-2-positive cells in villi exceeds by greater than fivefold that found in mesenteric lymph node or Peyer's patches. Overall, these temporal and spatial patterns of expression provide insight into the regulation of IL-2 in vivo and suggest a role for IL-2 expression distinct from immunological responses to antigen.
INTRODUCTION
Interleukin-2 (IL-2) has been best studied as a growth factor secreted by activated T cells in the course of the immune respohse. Its expression is strictly dependent on inducing stimuli, with requirements forseparate signals from Ca+2-dependent, ras-dependent, and *Corresponding author.
possibly additional signaling pathways (Jain et al., 1995; Serfling et al., 1995) . These requirements are met in mature T cells when they encounter antigen on antigen-presenting cells, thereby delivering coordinated signals triggered by the crosslinking of TcR/ CD3 complexes, CD4 (or CD8 in some cases), and CD28. Accordingly, analysis of the cis and trans regulatory elements critical for IL-2 expression has shown several discrete protein-DNA interactions that require activation by TcR/CD3-and/or CD28-dependent signaling mediators (Jain et al., 1995; Serfling et al., 1995) . The observation that IL-2 is also expressed primarily or exclusively by T cells has led to a general assumption that the primary function of IL-2 expression in vivo is to regulate T-cell clonal expansion as triggered by T-cell recognition of foreign antigen.
This assumption has been challenged in recent years by the phenotype of IL-2 "knockout" mice. Animals homozygous for targeted disruption of the IL-2 gene show initially normal numbers of T cells of various subsets and detectable but relatively subtle defects in their immediate proliferative responses to antigen (Schorle et al., 1991; Ktindig et al., 1993; Krimer et al., 1994; Cousens et al., 1995; Kneitz et al., 1995) . By contrast, multiple aspects of their longterm hematopoietic regulation and lymphocyte homeostasis are disrupted (Sadlack et al., 1993 (Sadlack et al., , 1995 Krimer et al., 1995; Reya, 1996) .
These findings raise several questions about the role of IL-2 expression in vivo. First, is IL-2 expressed in homeostatic contexts as well as in acute immune responses? Second, does IL-2 expression regulate hematopoietic populations in nonlymphoid tissues? Lastly, is mature cell behavior affected by prior exposure or lack of exposure to IL-2 during development? In order to address these questions, we systematically examined various organs of normal young mice to determine where IL-2 is detectably expressed. Our studies show that IL-2 mRNA and protein are associated with specific tissues in situ. These tissues invariably contain T cells, suggesting that IL-2 may be involved in regulating lymphocytic and/or hematopoietic function(s) at these sites.
RESULTS

Overall Distribution of IL-2-Expressing Cells in Neonatal Mice
To survey the range of tissues that might express the IL-2 gene in mice, neonatal mouse body sections were analyzed by in situ hybridization with 35S-labeled probes. The results of these analyses showed that most tissues of the body were devoid of hybridization above background, as established with sense-strand control probes. Brain, heart, lung, liver, stomach, bladder, and other parts of the body showed no evidence of IL-2 mRNA at this time (Yang-Snyder, 1994 ; data not shown). However, cells appearing to express IL-2 were seen reproducibly in three distinct domains: (1) the thymus, (2) the dermal region of the skin, and (3) the intestine. In neonatal animals, the intrathymic IL-2-producing cells appeared as individually labeled cells located predominantly in the inner cortical region, as described previously (Yang-Snyder and Rothenberg, 1993 
IL-2-Expressing Cells in Tissues of Weanling
Mice Based on these findings described IL-2 expression in the thymus, skin, and intestine of older animals was examined. In situ hybridization of isolated tissues from older weanling mice (3-4 weeks after birth) revealed that IL-2 mRNA cells continued to be detected in the thymus, skin, and gut (Yang-Snyder and  Figure 2 and data not shown). Likewise, IL-2 protein was also detected in these tissues at this stage (Yang-Snyder and Figures 3 and 4) . IL-2 expression in the thymus and gut remained relatively similar to that seen in neonatal animals, whereas IL-2 expression in the skin exhibited a marked spatial pattern of expression that changed according to the developmental age. These Importantly, the IL-2-reactive "zones" were specific, as this staining was blocked by an excess of recombinant murine IL-2 [ Figure 5( Figure (2 (Figure 4 ). Although isolated positive cells were observed by in situ hybridization of intestine samples taken from postweanling mice using 35S-labeled probes, nonspecific background as determined with the sense-strand control probe also increased significantly after birth (data not shown). Additionally, IL-2 protein was difficult to detect in the gut using conventional fresh-frozen sections (data not shown), but sensitivity of staining was enhanced greatly by prefixation of the tissue in paraformaldehyde ( Figure  4 ). In neonatal animals, the percentage of cells positive for detectable IL-2 protein was always significantly higher (--20-fold) than the cells with detectable IL-2 mRNA (data not shown). This did not reflect a lack of specificity in the immunohistochemical staining, but rather the increased persistence of the IL-2 protein as compared to the mRNA within the cell of origin and/or when associated with IL-2-binding target cells.
In weanling and postweanling animals, cells in both the small and large intestine were found to be immunoreactive to IL-2 antibody at relatively constant frequencies from 3 weeks to 3 months of age ( Figure 4 ). In these young adult animals, most intestinal staining was observed in lamina propriaassociated cells as opposed to intraepithelial cells.
Once again, the specificity of this staining was shown by antibody blocking using recombinant-derived murine IL-2 ( Figure 4 , right-hand panels). The frequency of IL-2 immunoreactive cells in the lamina propria was actually higher than the frequency of positive cells found in specialized lymphoid tissues, such as Peyer's patches and mesenteric lymph nodes (see Table 1 ), indicating that IL-2 expression in the gut is found predominantly in "nonlymphoid" sites in the gut.
Association of IL-2 Expression with the Presence of Mature T Cells in the Skin and Gut
In the thymus, the vast majority of cells are within the T-cell developmental lineage, and the morphology of IL-2 RNA cells as already reported indicates that these cells are part of the T-lineage majority rather than part of the minority of morphologically distinct stromal cells (Yang-Snyder and Rothenberg, 1993) .
T-lineage cells from the skin and gut have also been shown to express IL-2 when activated by immunological stimuli (Gramzinski et al., 1993; Matsue et al., 1993b; Guehler et al., 1996; Lundqvist et al., 1996) However, the connection between the developmental patterns of IL-2 production observed in these tissues and the presence of T cells remained to be defined. To determine whether IL-2 producers might colocalize with T cells in the skin and gut, ear epidermal sheets and gut sections were stained for the expression of Tcell markers.
In the skin, the distribution of IL-2 producers in follicle-associated clusters did not obviously correlate with any previous report of dendritic epidermal T-cell distribution (Miyauchi and Hashimoto, 1989 (Bosma and Carroll, 1991) . With respect to all other cell lineages, SCID animals are normal, and they remain fertile and healthy overall. In the skin, the scid mutation blocked the appearance of IL-2-expressing cells (Figure 9 ). Both IL-2 mRNA [Figure 9(C) Figure 11 (A). "Nests" of cells staining positively for IL-2 protein were already concentrated within villi. To establish how early IL-2 might be found in the gut, tissue from younger fetal animals was analyzed in parallel. By day 16 of gestation, rare IL-2 immunoreactive cells were already present in the gut, as shown in Figure 11 (B), albeit at a frequency (0.3 %) that was about tenfold lower than the frequency at day 19-20 of gestation. Although the origin of these IL-2 producers is not clear, we have previously shown that cells staining strongly for IL-2 protein are present in the fetal liver and omentum as well as the fetal thymus by day 15 of gestation (Havran et al., 1989 ). This lineage ,may have an unusually high sensitivity to IL-2, since it is preferentially expanded in fetal thymocyte populations that are cultured in the presence of high doses of IL-2 (Leclercq et al., 1990 (Leclercq et al., , 1992 and its development is especially sensitive to inhibition by antibodies against the IL-2-receptor /3 chain (CD122) (Tanaka et al., 1992) . In contrast, T cells entering the gut in fetal life may also be dominated by the use of a single V y segment IVy5 (7)] (Carding et al., 1990; Haas et al., 1993) , but the junctions and recognition specificities of their TcR are quite diverse. At least some of these cells are thought to be of extrathymic origin, but postthymic cells and cells apparently generated in situ contribute to the population, and may continue to seed the gut throughout life (Rocha et al., 1994 ; Lefrancois and Puddington, 1995 (Cao et al., 1995; DiSanto et al., 1995; Park et al., 1995 (Matsue et al., 1993a; Edelbaum et al., 1995) . However, the simple presence of these cells does not prove that they are functionally normal. Moreover, the disruption of the IL-2 gene leads to significant dysfunction in the gut and chronic inflammatory bowel disease, which contribute to the early mortality observed for IL-2-deficient mice (Sadlack et al., 1993) . The basis for this dysfunction is still under investigation, but it may be a result of the incomplete redundancy of functions of cytokines that share some but not all effects of IL-2 on target populations. There is evidence that IL-2 can participate directly in several kinds of autocrine or paracrine growth-stimulatory loops in the intestinal milieu throughout life (Ciacci et al., 1993; Gramzinski et al., 1993; Fujihashi et al., 1996) , and perhaps also play a role in restricting excessive lymphocyte activation (Kneitz et al., 1995) . Thus, the regulation of IL-2 expression in vivo, whether "immunological" or "nonimmunological," cannot be dismissed as functionally insignificant. The possible induction of IL-2 by nonimmunological signals raises fascinating questions of molecular mechanism for future study.
In conclusion, our studies raise the possibility that IL-2 expression in vivo might be controlled predominantly by signals not emanating from the clonotypic TcR. Though IL-2 gene regulation is perhaps the best studied of all lymphocyte responses to antigen stimulation (Jain et al., 1995; Serfling et al., 1995; Rothenberg and Ward, 1996) and the transcription factors that service the minimal enhancer of the IL-2 gene are now securely associated with termini of known signaling pathways emanating from the TcR/ CD3 and CD28 cell-surface receptors, the results presented here suggest that additional activation mechanisms exist that may be as fundamental for the overall biological role of IL-2 as are the familiar ones used in the "classical" immune response. From a molecular standpoint, it will be of great interest to determine the cell-surface receptor-ligand interactions responsible for inducing IL-2 expression in vivo and whether novel cis and trans regulatory elements are involved in regulating IL-2 expression. On a cellular level, further characterization of IL-2-producing and IL-2-responsive cells will undoubtedly increase understanding of such "nonimmunological" functions of IL-2 in vivo.
MATERIALS AND METHODS
Mice C57BL/6 Tla mice, transgenic mice with an cq3-TcR specific for H-2L d (Sha et al., 1988) , and C.B-17-scid (SCID) mice were bred and maintained in our own facility. The SCID breeders were carefully selected to maintain a particularly low level of "leakiness" in their progeny, as described previously . All SCID animals were maintained in an Isotec flexible film isolator (Indianapolis, IN) with autoclaved food, water, and bedding, but without antibiotic treatment. 2C cq3-TcR transgenic animals, a generous gift from William Sha and Dennis Loh, were rederived to be virus-free by embryo transfer, backcrossed to either B10 (Jackson Laboratories, Bar Harbor, ME) or B 10.S (Charles River Laboratories, Willmington, MA) genetic backgrounds, and kept on sterile food and bedding. Regular monitoring of our colony verified that animals used were pathogen-free (data not shown). Neonatal animals were taken within 12 hr after birth. Fetal tissues were taken from fetuses removed from pregnant BL/6 Tla and SCID mothers using timed matings. The appearance of a vaginal plug was designated as day 0.
Removal and Processing of Tissues
Activated lymph node and fetal thymus samples were prepared as described in (Yang-Snyder and Rothenberg, 1993 
